DURECT Inks Co-marketing And Collaboration Deal With Charles River For ALZET Product Line

Charles River Laboratories Slashes FY24 Outlook - Update

RTTNews | 385天前

Charles River Laboratories Reaffirms FY24 Outlook; Q1 Results Top Estimates

While reporting financial results for the first quarter on Thursday, Charles River Laboratories International, Inc. (CRL) reaffirmed its adjusted earnings, revenue growth and organic revenue growth guidance range for the full-year 2024.

RTTNews | 475天前

Charles River Laboratories Narrows FY23 Outlook Range; Q3 Results Top Estimates

While reporting financial results for the first quarter on Thursday, Charles River Laboratories International, Inc. (CRL) narrowed its earnings, adjusted earnings, revenue growth and organic revenue growth guidance range for the full-year 2023.

RTTNews | 658天前

Charles River Labs Boosts FY23 Outlook As Q2 Results Top Estimates

While reporting financial results for the first quarter on Thursday, Charles River Laboratories International, Inc. (CRL) raised its adjusted earnings, revenue growth and organic revenue growth guidance for the full-year 2023, to reflect the strong first-quarter financial performance and expectations for the remainder of the year that are largely consistent with its initial outlook.

RTTNews | 839天前

Charles River Labs Slashes FY22 Outlook; Q2 Adj. EPS Tops Estimates, Revenues Miss

While reporting financial results for the second quarter on Wednesday, Charles River Laboratories International, Inc. (CRL) slashed its earnings, adjusted earnings, revenue growth and organic revenue growth guidance for the full-year 2022, due primarily to headwinds associated with the CDMO business, foreign exchange, and interest expense due to the rising interest rate environment.

RTTNews | 1120天前

DURECT Appoints Timothy Papp As New CFO

Biopharmaceutical company DURECT Corp. (DRRX) announced Tuesday the appointment of Timothy Papp as its Chief Financial Officer. Papp brings over 25 years of corporate finance experience to DURECT, including 15 years in the Biopharma sector.

RTTNews | 1149天前

FTSE 100 Flat In Lackluster Trade; Bank Stocks Drifting Lower

U.K. stocks are somewhat subdued in lackluster trade on Wednesday as investors remain a bit reluctant to make significant moves due to a lack of triggers. The benchmark FTSE 100 was at 9,266.25 a little before noon, up 0.45 points over previous close.

RTTNews | 14分鐘前

CAC 40 Advances After Recent Losses

Despite the uncertainty on the political front, the French market is up in positive territory on Wednesday due largely to some bargain hunting at several counters after two successive days of declines. Investors are also looking ahead to AI giant Nvidia's earnings updates.

RTTNews | 28分鐘前

EURUSD	1.15864	GBPUSD	1.34337	AUDUSD	0.64686
USDJPY	148.05	USDCAD	1.38454	USDCHF	0.80671